(Q41580725)

4 October 2017

title

Hydralazine-induced lupus: is there a toxic metabolic pathway? (English)

1 reference

4 October 2017

J A Timbrell

1

1 reference

4 October 2017

V Facchini

series ordinal

2

1 reference

4 October 2017

S J Harland

series ordinal

3

1 reference

4 October 2017

R Mansilla-Tinoco

series ordinal

4

1 reference

4 October 2017

publication date

1 January 1984

1 reference

European Journal of Clinical Pharmacology

4 October 2017

published in

1 reference

4 October 2017

volume

27

1 reference

4 October 2017

issue

5

1 reference

4 October 2017

page(s)

555-559

1 reference

Determination of hydralazine metabolites: 4-hydrazino-phthalazin-1-one and n-acetylhydrazinophthalazin-1-one by gas chromatography and s-triazolo[3,4-alpha]phthalazine and phthalazinone by high-performance liquid chromatography

4 October 2017

cites work

1 reference

12 December 2020

Polymorphic acetylation of hydralazine

1 reference

12 December 2020

Identification and quantitation of hydrazine in the urine of patients treated with hydralazine

1 reference

12 December 2020

Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects

1 reference

12 December 2020

Enzyme-mediated covalent binding of hydralazine to rat liver microsomes

1 reference

12 December 2020

Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype

1 reference

12 December 2020

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

1 reference

12 December 2020

Determination of hydralazine and its acetylated metabolites in urine by gas chromatography and high-pressure liquid chromatography

1 reference

12 December 2020

The comeback of hydralazine

1 reference

12 December 2020

Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.

1 reference

12 December 2020

The in vitro metabolism of hydralazine

1 reference

12 December 2020

An improved and simplified method of detecting the acetylator phenotype

1 reference

12 December 2020

Hydralazine, antinuclear antibodies, and the lupus syndrome

1 reference

12 December 2020

Syndrome simulating collagen disease caused by hydralazine (Apresoline)

1 reference

12 December 2020

Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility

1 reference

12 December 2020

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

1 reference

12 December 2020

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine

1 reference

12 December 2020

Physiological disposition of hydralazine (1-hydrazinophthalazine) and a method for its determination in biological fluids

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00556891

1 reference

4 October 2017

1 reference